BCRX
BioCryst Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BCRX fundamentals
BioCryst Pharmaceuticals (BCRX) released its earnings on Nov 3, 2025: revenue was 159.10M (YoY +35.88%), missed estimates; EPS was 0.16 (YoY +328.57%), beat estimates.
Revenue / YoY
159.10M
+35.88%
EPS / YoY
0.16
+328.57%
Report date
Nov 3, 2025
BCRX Earnings Call Summary for Q3,2025
- Revenue Surge: ORLADEYO up 37% YoY to $159.1M, with U.S. sales dominating at 89%. Full-year guidance raised to $590-600M.
- Strategic Wins: European sale & debt repayment; $400M Astria acquisition for navenibart.
- Pipeline Momentum: BCX17725 skin penetration in healthy volunteers; DME program to be spun/partnered.
- Financial Strength: $269M cash pre-close; 2025 non-GAAP net income positive.
- Pediatric Play: 500 diagnosed pediatric HAE patients; PDUFA mid-Dec with payer alignment intact.
EPS
Revenue
Revenue & Expenses
BCRX has released its 2025 Q3 earnings report, with revenue of 159.40M, reflecting a YoY change of 36.14%, and net profit of 12.90M, showing a YoY change of 191.92%. The Sankey diagram below clearly presents BCRX's revenue sources and cost distribution.
Key Indicators
BioCryst Pharmaceuticals (BCRX) key financial stats and ratios, covering profitability, financial health, and leverage.
BioCryst Pharmaceuticals (BCRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
BioCryst Pharmaceuticals (BCRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
BioCryst Pharmaceuticals (BCRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does BioCryst Pharmaceuticals (BCRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track BioCryst Pharmaceuticals (BCRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for BioCryst Pharmaceuticals next quarter?What factors drove the changes in BioCryst Pharmaceuticals's revenue and profit?What were the key takeaways from BioCryst Pharmaceuticals’s earnings call?What guidance did BioCryst Pharmaceuticals's management provide for the next earnings period?Did BioCryst Pharmaceuticals beat or miss consensus estimates last quarter?What is BioCryst Pharmaceuticals's gross profit margin?What were the key takeaways from BioCryst Pharmaceuticals's earnings call?What is BioCryst Pharmaceuticals's latest dividend and current dividend yield?
